Why Balchem Stock Jumped Today
Key Points
Balchem reported record third-quarter sales.
The company is growing sales while also supporting new growth initiatives.
- 10 stocks we like better than Balchem ›
Many people may not know Balchem (NASDAQ: BCPC). The company works to find solutions to problems facing the nutrition, health, and food markets. The human and animal nutrition product company just reported record third-quarter sales, and the stock is jumping today.
Balchem shares rose over 5% this morning and remained higher by 3.8% as of 12:20 p.m. ET.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Image source: Getty Images.
The health trend isn't going away
Balchem specializes in the development, manufacturing, and sales of specialty performance ingredients supporting both human and animal nutrition and health. Its dietary supplements and nutrition-strengthening solutions are gaining users. Balchem also has encapsulation technologies for better nutrient delivery.
Record third-quarter sales grew 11.5% year over year. CEO Ted Harris stated:
In the third quarter, our company continued to deliver strong growth, fueled by the ongoing market penetration of our unique portfolio of specialty nutrients and delivery systems, and the favorable 'better for you' trends within the food and nutrition markets that are well aligned with our food ingredient formulation systems and capabilities.
Investors may have especially liked the generation of $51 million in free cash flow. That helped Balchem pay down a meaningful portion of its debt.
What Balchem is up to
Despite a recent surge, Balchem stock hasn't done much this year. Investors may be waiting for more results from the company's studies surrounding choline intake and human health. Balchem is also investing to double its domestic capacity of its fast-growing nutrient delivery technologies. It believes that investment will deliver strong returns. Some investors jumped into Balchem stock today, expecting to soon see further growth in sales and profits.
Should you invest $1,000 in Balchem right now?
Before you buy stock in Balchem, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Balchem wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $667,945!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,119,558!*
Now, it’s worth noting Stock Advisor’s total average return is 1,073% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of October 20, 2025
Howard Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Recommended Articles
